Your browser doesn't support javascript.
loading
D variants in the population of D-negative blood donors in the north-eastern region of Croatia.
Safic Stanic, Hana; Dogic, Vesna; Herceg, Ivona; Jagnjic, Sandra; Bingulac-Popovic, Jasna; Babic, Ivana; Corusic, Ante; Jukic, Irena.
  • Safic Stanic H; Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
  • Dogic V; Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
  • Herceg I; Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
  • Jagnjic S; Department of Immunohematology, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
  • Bingulac-Popovic J; Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
  • Babic I; Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
  • Corusic A; Directory, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Jukic I; School of Medicine, University of Zagreb, Zagreb, Croatia.
Transfus Med ; 31(1): 43-47, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33034130
ABSTRACT

OBJECTIVES:

The aim of this study was to determine RHESUS D GENE (RHD) allelic variants among Croatian D-negative blood donors and compare our results with respective data from other European countries.

BACKGROUND:

Altered or reduced D antigen expression can result in D variants, which can be mistyped and can lead to the alloimmunisation of the blood recipient. RHD genotyping can distinguish D variants weak D, partial D and DEL, thus preventing alloimmunisation. MATERIAL/

METHODS:

A total of 6523 samples obtained from D-negative Croatian donors were screened for the presence of RHD using the real-time polymerase chain reaction (PCR) method. PCR-SSP was performed for D variant genotyping by using commercial genotyping kits (Inno-Train, Kronberg, Germany). Genomic DNA sequencing for all 10 exons of the RHD was performed when the genotyping kits failed to assign a D variant.

RESULTS:

RHD molecular screening revealed 23 (0.35%) RHD-PCR positive samples, all C/E positive, in decreasing frequency 11 hybrid RHD-CE (2-9) D-CE variants, 4 weak partial D type 11 and 2 weak D type 2. Six samples remained unresolved and were sequenced. For 12 of 23 samples (excluding large hybrids), an adsorption/elution of anti-D serum was performed, confirming that all 12 were RhD+. The calculated frequency of clinically significant D alleles in RhD-negative blood donors was 1543 (0.18%) or 153 (1.89%) in C/E blood donors.

CONCLUSION:

Data on the significant frequency of D variants among serologically D-negative blood donors in the north-eastern region of Croatia could help in introducing RHD molecular screening of blood donors in a routine workflow.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistema del Grupo Sanguíneo Rh-Hr / Donantes de Sangre / Polimorfismo Conformacional Retorcido-Simple / Técnicas de Genotipaje / Genotipo Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistema del Grupo Sanguíneo Rh-Hr / Donantes de Sangre / Polimorfismo Conformacional Retorcido-Simple / Técnicas de Genotipaje / Genotipo Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article